Hem › Icke-småcellig lungcancer › New Mexico
Kliniska studier för Icke-småcellig lungcancer i New Mexico
22 studier för Icke-småcellig lungcancer söker deltagare vid platser i New Mexico.
Städer i New Mexico
Officiell studietext (engelska)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- University of New Mexico Cancer Center, Albuquerque
- Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT04267848A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
- University of New Mexico - Comprehensive Cancer Center, Albuquerque
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07365319Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- University of New Mexico Cancer Center, Albuquerque
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06498635A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- CHRISTUS St. Vincent Regional Cancer Center, Santa Fe
- Christus St. Vincent Regional Medical Center, Santa Fe
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07144280Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- University of New Mexico Comprehensive Cancer Center, Albuquerque
- CHRISTUS St. Vincent Regional Cancer Center, Santa Fe
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07222566A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- University of New Mexico Cancer Center, Albuquerque
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05920356Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- New Mexico Oncology Hematology Consultants, Ltd, Albuquerque
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07489066A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- University of New Mexico, Albuquerque
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06667076Pan-tumor MRD Study
- San Juan Oncology Associates, Farmington
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06605404Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- New Mexico Oncology Hematology Consultants, Albuquerque
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07028489An External Control Arm Study in Non-Small Cell Lung Cancer
- New Mexico Oncology Hematology Consultants, Albuquerque
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07174388A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- San Juan Oncology Associates, Farmington
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07541170A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- San Juan Oncology Associates, Farmington
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of New Mexico Comprehensive Cancer Center, Albuquerque
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
- Research Site, Albuquerque
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07291037Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- University of New Mexico Comprehensive Cancer Center ( Site 0135), Albuquerque
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06422143Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- University of New Mexico Cancer Center, Albuquerque
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 3 juni 2026 · NCT05642572Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- University of New Mexico Cancer Center, Albuquerque
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT06616584Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Lovelace Medical Center-Saint Joseph Square, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
- Lovelace Women's Hospital, Albuquerque
- och 3 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Presbyterian Kaseman Hospital (site 208), Albuquerque
RekryterarFas 1/2
Ålder 18 till 80 · Alla kön · Uppdaterad 11 dec. 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Albuquerque
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774BostonGene and Exigent Genomic INsight Study
- New Mexico Cancer Center, Albuquerque
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 feb. 2025 · NCT06272864Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.